Mitchell S. Cairo

27.5k total citations · 2 hit papers
507 papers, 14.9k citations indexed

About

Mitchell S. Cairo is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mitchell S. Cairo has authored 507 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 161 papers in Oncology and 153 papers in Pathology and Forensic Medicine. Recurrent topics in Mitchell S. Cairo's work include Hematopoietic Stem Cell Transplantation (144 papers), Lymphoma Diagnosis and Treatment (141 papers) and Acute Lymphoblastic Leukemia research (120 papers). Mitchell S. Cairo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (144 papers), Lymphoma Diagnosis and Treatment (141 papers) and Acute Lymphoblastic Leukemia research (120 papers). Mitchell S. Cairo collaborates with scholars based in United States, United Kingdom and France. Mitchell S. Cairo's co-authors include Michael Bishop, Carmella van de Ven, John E. Wagner, Sherrie L. Perkins, Anas Younes, Bertrand Coiffier, Erin Morris, Richard Sposto, Joanne Kurtzberg and Janet Ayello and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mitchell S. Cairo

492 papers receiving 14.5k citations

Hit Papers

Hematopoietic Engraftment... 2001 2026 2009 2017 2001 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
    2001 643 citations John E. Wagner, Mitchell S. Cairo et al. profile →
  2. Tumour lysis syndrome: new therapeutic strategies and classification
    2004 639 citations Mitchell S. Cairo et al. British Journal of Haematology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mitchell S. Cairo 4.8k 4.5k 3.3k 3.0k 3.0k 507 14.9k
Helmut Gadner 6.5k 1.3× 3.9k 0.9× 3.3k 1.0× 2.9k 1.0× 4.8k 1.6× 408 20.4k
Lothar Kanz 6.3k 1.3× 6.6k 1.5× 2.0k 0.6× 6.3k 2.1× 2.8k 0.9× 579 22.1k
Martin Schrappe 7.5k 1.6× 3.8k 0.8× 2.7k 0.8× 1.7k 0.6× 905 0.3× 387 18.7k
Koen van Besien 6.9k 1.4× 4.4k 1.0× 2.9k 0.9× 3.2k 1.1× 665 0.2× 354 12.0k
Donna Przepiorka 12.0k 2.5× 5.5k 1.2× 1.6k 0.5× 5.6k 1.9× 1.0k 0.3× 197 18.2k
Jürgen Finke 6.9k 1.4× 3.8k 0.8× 2.6k 0.8× 3.4k 1.1× 652 0.2× 396 12.9k
Eckhard Thiel 2.5k 0.5× 3.1k 0.7× 2.7k 0.8× 3.4k 1.1× 661 0.2× 260 11.9k
Anna Sureda 5.0k 1.0× 5.6k 1.2× 4.5k 1.4× 2.2k 0.7× 758 0.3× 465 11.7k
Maurizio Aricò 8.5k 1.8× 1.9k 0.4× 1.4k 0.4× 6.0k 2.0× 896 0.3× 315 16.5k
Peter Dreger 5.4k 1.1× 4.6k 1.0× 3.7k 1.1× 3.2k 1.1× 680 0.2× 408 11.6k

Countries citing papers authored by Mitchell S. Cairo

Since Specialization
Citations

This map shows the geographic impact of Mitchell S. Cairo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell S. Cairo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell S. Cairo more than expected).

Fields of papers citing papers by Mitchell S. Cairo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell S. Cairo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell S. Cairo. The network helps show where Mitchell S. Cairo may publish in the future.

Co-authorship network of co-authors of Mitchell S. Cairo

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell S. Cairo. A scholar is included among the top collaborators of Mitchell S. Cairo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell S. Cairo. Mitchell S. Cairo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hirani, Rahim, et al.. (2025). Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 145(7). 1813–1816. 2 indexed citations
3.
Hirani, Rahim, et al.. (2024). Modulation of Inflammation By Unrestricted Somatic Stem Cells (USSCs) to Suppress Fibrosis in Mice with Dystrophic Epidermolysis Bullosa. Transplantation and Cellular Therapy. 30(2). S63–S64. 1 indexed citations
4.
Chu, Yaya, Uksha Saini, M. Fevzi Özkaynak, et al.. (2024). Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma. SHILAP Revista de lepidopterología. 33(1). 200927–200927. 5 indexed citations
5.
Parsons, Susan K., Angie Mae Rodday, Erin Morris, et al.. (2022). Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant. Bone Marrow Transplantation. 57(4). 586–592. 4 indexed citations
6.
7.
Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations
8.
Ahmed, Jibran, et al.. (2021). The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia. Blood. 138(Supplement 1). 2148–2148. 1 indexed citations
9.
Chu, Yaya, Gaurav Nayyar, Nang Kham Su, et al.. (2020). Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Journal for ImmunoTherapy of Cancer. 8(2). e001238–e001238. 11 indexed citations
10.
Cairo, Mitchell S. & Auke Beishuizen. (2019). Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives. British Journal of Haematology. 185(6). 1021–1042. 31 indexed citations
11.
Flower, Allyson, Ana C. Xavier, & Mitchell S. Cairo. (2019). Mature (non‐anaplastic, non‐cutaneous) T‐/NK‐cell lymphomas in children, adolescents and young adults: state of the science. British Journal of Haematology. 185(3). 418–435. 8 indexed citations
12.
Dvorak, Christopher C., Prakash Satwani, Elliot Stieglitz, et al.. (2018). Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatric Blood & Cancer. 65(7). e27034–e27034. 23 indexed citations
13.
Cairo, Mitchell S., Anne Aupérin, Sherrie L. Perkins, et al.. (2018). Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group. British Journal of Haematology. 182(6). 859–869. 37 indexed citations
14.
15.
Chu, Yaya, Jessica Hochberg, Janet Ayello, et al.. (2014). Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice. Cancer Immunology Research. 3(4). 333–344. 143 indexed citations
16.
Smith, Lynette M., James R. Anderson, Minnie Abromowitch, et al.. (2012). The immunophenotype of T ‐lymphoblastic lymphoma in children and adolescents: a C hildren's O ncology G roup report. British Journal of Haematology. 159(4). 454–461. 69 indexed citations
17.
Meehan, Kenneth R., Rebecca Slack, Edmund A. Gehan, et al.. (2002). Mobilization of Peripheral Blood Stem Cells with Paclitaxel and rhG-CSF in High-Risk Breast Cancer Patients. Journal of Hematotherapy & Stem Cell Research. 11(2). 415–421. 4 indexed citations
18.
Fraser, John K., Mitchell S. Cairo, Elizabeth L. Wagner, et al.. (1998). Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures. Journal of Hematotherapy. 7(6). 521–561. 84 indexed citations
19.
Ishizawa, Lori, Giao Hangoc, Carmella van de Ven, et al.. (1993). Immunomagnetic Separation of CD34 + Cells from Human Bone Marrow, Cord Blood, and Mobilized Peripheral Blood. Journal of Hematotherapy. 2(3). 333–338. 18 indexed citations
20.
Law, Ping‐Yee, Lori Ishizawa, Carmella van de Ven, et al.. (1993). Immunomagnetic Positive Selection and Colony Culture of CD34 + Cells from Blood. Journal of Hematotherapy. 2(2). 247–250. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Gadner Breakdown of academic impact, for papers by Lothar Kanz Breakdown of academic impact, for papers by Martin Schrappe Breakdown of academic impact, for papers by Koen van Besien Breakdown of academic impact, for papers by Donna Przepiorka Breakdown of academic impact, for papers by Jürgen Finke Breakdown of academic impact, for papers by Eckhard Thiel Breakdown of academic impact, for papers by Anna Sureda Breakdown of academic impact, for papers by Maurizio Aricò Breakdown of academic impact, for papers by Peter Dreger
Rankless by CCL
2026